Science in the News
FDA warns against use of homeopathic teething gels and tablets
October 04, 2016
On September 30, 2016, the U.S. Food and Drug Administration warned consumers that homeopathic teething tablets and gels may pose a risk to infants and children.1
The FDA recommended that consumers stop using these products and dispose of any in their possession. Although homeopathic treatments are regulated as drugs under the Federal Food, Drug, and Cosmetic Act, the FDA does not evaluate the remedies for safety or effectiveness.2
Manufacturers of homeopathic teething gels and tablets list ingredients such as Calcarea Phosphorica, Chamomilla, Coffea Cruda, Belladonna, Calcarea Carbonica, Passiflora Incarnata, and Terebinhina.
According to the FDA, "Consumers should seek medical care immediately if their child experiences seizures, difficulty breathing, lethargy, excessive sleepiness, muscle weakness, skin flushing, constipation, difficulty urinating, or agitation after using homeopathic teething tablets or gels."
The FDA is analyzing adverse events reported to the agency regarding homeopathic teething tablets and gels since a 2010 FDA consumer safety alert on teething tablets.3
The FDA urges both health care professionals and consumers to report adverse events to the FDA’s MedWatch Adverse Event Reporting program.4
Prepared by: Center for Scientific Information, ADA Science Institute
- U.S. Food and Drug Administration. FDA warns against the use of homeopathic teething tablets and gels; 2016.
- National Center for Complementary and Integrative Health Homeopathy. 2015.
- U.S. Food and Drug Administration. Hyland’s Teething Tablets may pose a risk to children; 2010.
- U.S. Food and Drug Administration MedWatch: The FDA Safety Information and Adverse Event Reporting Program. 2016.
About Science in the News
Science in the News is a service by the American Dental Association (ADA) to its members to present current information about science topics in the news. The ADA is a professional association of dentists committed to the public's oral health, ethics, science and professional advancement; leading a unified profession through initiatives in advocacy, education, research and the development of standards. As a science-based organization, the ADA's evaluation of the scientific evidence may change as more information becomes available. Your thoughts would be greatly appreciated.